Aprecia Pharmaceuticals Co — Form D

Aprecia Pharmaceuticals Co of LANGHORNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-29. The offering totals $500K, of which $500K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Jaedok YooExecutive OfficerEast Windsor, NJ
Michael KingExecutive OfficerROAD TOWN, TORTOLA, D8
Etienne Thomas PeroldDirectorPennington, NJ
Michael Thomas RolhfsExecutive OfficerBlue Ash, OH
David Thomas FurnissExecutive OfficerMason, OH
Robert Thomas WillifordExecutive OfficerBlue Ash, OH
James Thomas EvansDirectorCincinnati, OH
Lawrence Thomas GlassmannDirectorBlue Ash, OH
Lawrence Thomas GlassmannExecutive OfficerBlue Ash, OH
E Thomas AringtonDirectorMason, OH
E Thomas AringtonExecutive OfficerMason, OH
Donald Thomas WetherholdExecutive OfficerBlue Ash, OH
Jonathan Thomas LeffDirectorNew York, NY
Michael Thomas RohlfsExecutive OfficerWest Chester, OH
DAVID A FURNISSExecutive OfficerCINCINNATI, OH
ROBERT A WILLIFORDExecutive OfficerCINCINNATI, OH
MICHAEL A ROHLFSExecutive OfficerWEST CHESTER, OH
Etienne A PeroldDirectorPennington, NJ
Etienne A PeroldExecutive OfficerPennington, NJ
DONALD A WETHERHOLDExecutive OfficerLOVELAND, OH
Glenn S VraniakExecutive OfficerManalapan, NJ
Michael S KingExecutive OfficerPrinceton, NJ
Donald C MonkhouseExecutive OfficerRadnor, PA
Don S WetherholdExecutive OfficerLoveland, OH
Michael C KingExecutive OfficerPrinceton, NJ

Other filings by this issuer (11)

FiledFormOfferingSold
2016-01-28D$84.0M$79.0M
2015-08-31D$52.0M$38.8M
2013-12-10D/A$36.3M$14.9M
2013-12-09D$36.2M$14.9M
2012-11-19D$8.6M$4.0M
2011-11-04D$25.7M$25.7M
2010-12-20D/A$4.9M$3.9M
2010-11-08D/A$455K$455K
2010-10-18D$105K$105K
2010-01-25D/A$5.5M$5.5M
2009-12-24D$2.5M$2.5M

More